表紙
市場調查報告書
商品編碼
1033260

多重化驗的全球市場:各產品、類型、科技、應用(研究開發、臨床診斷)、終端用戶、地區,預測和機會(2026年)

Global Multiplex Assays Market, By Product, By Type, By Technology, By Application (Research & Development, Clinical Diagnosis, By End User, By Region, forecast & opportunities, 2026

出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

  • 全貌
  • 簡介
  • 目錄
簡介

全球多重化驗市場,由於醫療領域的技術進步,尤其是奈米技術的迅速發展,在預測期間內預計大幅度成長。

本報告提供全球多重化驗市場的相關調查,市場規模和預測,佔有率,COVID-19的影響,成長要素和課題,各產品、科技、應用、終端用戶、企業、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球多重化驗市場的影響

第4章 摘要整理

第5章 客戶的迴響

第6章 全球多重化驗市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品(試劑與消耗品,配件和設備,軟體與服務)
    • 各類型(核酸,蛋白質,細胞為基礎)
    • 各科技(流式細胞技術,螢光檢測,發光,多重即時PCR,其他)
    • 各應用領域(研究開發,臨床診斷)
    • 各終端用戶(製藥、生物科技企業,醫院、研究,索引實驗室,其他)
    • 各企業(2021年)
    • 各地區
  • 產品市場地圖

第7章 亞太地區的多重化驗市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各科技
    • 各應用領域
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第8章 歐洲多重化驗市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各科技
    • 各應用領域
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第9章 北美多重化驗市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各科技
    • 各應用領域
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國
    • 墨西哥
    • 加拿大

第10章 南美的多重化驗市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各科技
    • 各應用領域
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西
    • 哥倫比亞

第11章 中東及非洲的多重化驗市場預測

  • 市場規模與預測
    • 各銷售額
  • 市場佔有率與預測
    • 各產品
    • 各類型
    • 各科技
    • 各應用領域
    • 各終端用戶
    • 各國
  • 中東、非洲:各國分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • 競爭預測
  • 企業簡介
    • Abbott Laboratories, Inc.
    • Thermo Fisher Scientific, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • BUHLMANN Laboratories AG
    • Sekisui Medical Co., Ltd.
    • Randox Laboratories Ltd.

第15章 策略性建議

第16章 關於本公司&免責聲明

目錄
Product Code: 5055

Global multiplex assays market is expected to undergo substantial rate of growth during the forecast period owing to technological advancements in healthcare sector, especially rapid development in nano technology. Increasing prevalence of chronic diseases including cancer, where multiplex assays are significantly used, is also a major driving factor for the growth of this market. Additionally, various benefits of multiplex assays over singleplex and other traditional diagnostics is also anticipated to fuel the growth of multiplex market in the years to come.

Multiplex assay is a type of assay which measures multiple analytes in a single cycle. They are widely used in functional genomics to determine the effects of experimental treatments. A multiplex assay detects proteins and other biomolecules in a biological sample.

Global multiplex assays market can be segmented based on product, type, technology, application, end user and region. Based on technology, the market is segmented into flow cytometry, fluorescence detection, luminescence, multiplex real-time PCR and others. The flow cytometry segment is expected to undergo significant growth during the forecast period as it works on the basis of bead population, which is helpful in computing specific antibody levels in biological fluids.

Region wise, North America is expected to dominate the global multiplex assays market by 2026 owing to regions' advanced healthcare system and availability of trained professionals. Various governments in the region are also supporting the development of advanced technologies for diagnostics, which is giving a major boost to multiplex assay companies.

Major companies operating in global multiplex assays market include Thermo Fisher Scientific Inc, Luminex Corporation, Illumina Inc, Qiagen N.V., Bio Rad Laboratories Inc, Abcam Plc, Agilent Technologies, Merck Sharp & Dohme Corp, Randox Laboratories Ltd, Meso Scale Diagnostics LLC, Seegene Inc., Becton, Dickinson and Company, Quansys Biosciences, Olink, Bio-Techne, Johnson & Johnson Services, Inc. and Hoffmann-La Roche Ltd, among others. Prominent market players are extensively undergoing research and development activities in order to introduce superior quality assays in the market.

Years considered for this report:

Historical Years: 2016-2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022-2026

Objective of the Study:

  • To analyze and forecast the market size of global multiplex assays market.
  • To forecast global multiplex assays market based on product, type, technology, application, end user, company and regional distribution.
  • To identify drivers and challenges for global multiplex assays market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global multiplex assays market.
  • To identify and analyze the profile of leading players operating in the global multiplex assays market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of multiplex assays manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global multiplex assays market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Multiplex assays manufacturers, vendors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to multiplex assays
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as multiplex assays manufacturing companies, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global multiplex assays market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Multiplex Assays Market, By Product:

Reagents & Consumables

Accessories & Instruments

Software & Services

  • Global Multiplex Assays Market, By Type:

Nucleic Acid

Protein

Cell-based

  • Global Multiplex Assays Market, By Technology:

Flow Cytometry

Fluorescence Detection

Luminescence

Multiplex Real-Time PCR

Others

  • Global Multiplex Assays Market, By Application:

Research & Development

  • Drug Development
  • Biomarker Discovery & Validation

Clinical Diagnosis

  • Infectious Disease
  • Cancer
  • Cardiovascular Disease
  • Autoimmune Disease
  • Nervous System Disorders
  • Others
  • Global Multiplex Assays Market, By End User:

Pharmaceutical & Biotechnology Companies

Hospitals & Research Institutes

Reference Laboratories

Others

  • Global Multiplex Assays Market, By Region:

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Europe

  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

North America

  • United States
  • Mexico
  • Canada

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global multiplex assays market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Multiplex Assays Market

4. Executive Summary

5. Voice of Customer

6. Global Multiplex Assays Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 6.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 6.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 6.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 6.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 6.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 6.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 6.2.6. By Company (2021)
    • 6.2.7. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Multiplex Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 7.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 7.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 7.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 7.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 7.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 7.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 7.2.6. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Multiplex Assays Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. India Multiplex Assays Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Japan Multiplex Assays Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. South Korea Multiplex Assays Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Australia Multiplex Assays Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Europe Multiplex Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 8.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 8.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 8.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 8.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 8.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 8.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 8.2.6. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Multiplex Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. Germany Multiplex Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. United Kingdom Multiplex Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. Italy Multiplex Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Spain Multiplex Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. North America Multiplex Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 9.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 9.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 9.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 9.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 9.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 9.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 9.2.6. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Multiplex Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Mexico Multiplex Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Canada Multiplex Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Multiplex Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 10.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 10.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 10.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 10.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 10.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 10.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Multiplex Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Multiplex Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User

11. Middle East and Africa Multiplex Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product (Reagents & Consumables, Accessories & Instruments, Software & Services)
    • 11.2.2. By Type (Nucleic Acid, Protein, Cell-based)
    • 11.2.3. By Technology (Flow Cytometry, Fluorescence Detection, Luminescence, Multiplex Real-Time PCR, Others)
    • 11.2.4. By Application (Research & Development v/s Clinical Diagnostics)
      • 11.2.4.1. Research & Development (Drug Discovery & Development v/s Biomarker Discovery & Validation)
      • 11.2.4.2. By Clinical Diagnostics (Infectious Diseases, Cancer, Cardiovascular Diseases, Autoimmune Diseases, Nervous System Disorders, Others)
    • 11.2.5. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories, Others)
    • 11.2.6. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Multiplex Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Type
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Saudi Arabia Multiplex Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Type
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. UAE Multiplex Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Type
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
    • 14.2.1. Abbott Laboratories, Inc.
    • 14.2.2. Thermo Fisher Scientific, Inc.
    • 14.2.3. Danaher Corporation
    • 14.2.4. F. Hoffmann-La Roche AG
    • 14.2.5. Siemens Healthineers AG
    • 14.2.6. Bio-Rad Laboratories, Inc.
    • 14.2.7. bioMerieux SA
    • 14.2.8. BUHLMANN Laboratories AG
    • 14.2.9. Sekisui Medical Co., Ltd.
    • 14.2.10. Randox Laboratories Ltd.

15. Strategic Recommendations

16. About Us & Disclaimer